Literature DB >> 11713951

Usefulness of magnetic resonance spectroscopy for diagnosis of hepatic encephalopathy in a patient with relapsing confusional syndrome.

J Cordoba1, C Hinojosa, F Sampedro, J Alonso, A Rovira, S Quiroga, R Esteban, J Guardia.   

Abstract

Magnetic resonance spectroscopy allows the assessment of several metabolites in brain tissue. In patients with hepatic encephalopathy, this technique shows a rise in glutamine and a decrease in myoinositol in brain tissue. However, the role of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy is not known. We report the case of a patient with a relapsing confusional syndrome who underwent magnetic resonance spectroscopy. Previously, hepatic encephalopathy was ruled out because of the negative results of a transjugular liver biopsy and normal hepatic venous pressure gradient. The results of magnetic resonance were characteristic of hepatic encephalopathy. Abdominal computed tomography demonstrated large portosystemic shunts associated with cirrhosis of the liver. This case shows that magnetic resonance spectroscopy is an useful technique for the diagnosis of hepatic encephalopathy in selected cases, such as those without clinical signs of cirrhosis and/or large portosystemic shunts.

Entities:  

Mesh:

Year:  2001        PMID: 11713951     DOI: 10.1023/a:1012323819757

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Effects of portal-systemic shunt embolization on the basal ganglia: MRI.

Authors:  S Matsumoto; H Mori; K Yoshioka; H Kiyosue; E Komatsu
Journal:  Neuroradiology       Date:  1997-05       Impact factor: 2.804

2.  NMR spectroscopy in portal-systemic encephalopathy: are we there yet?

Authors:  S Schenker; R Butterworth
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

3.  Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy.

Authors:  B T Hourani; E M Hamlin; T B Reynolds
Journal:  Arch Intern Med       Date:  1971-06

4.  Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.

Authors:  D J Meyerhoff; C Bloomer; V Cardenas; D Norman; M W Weiner; G Fein
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

5.  [The applicability and diagnostic effectiveness of transjugular liver biopsy].

Authors:  R Trejo; W Alvarez; J C García-Pagán; F Feu; A Escorsell; M Bruguera; J Bosch; J Rodés
Journal:  Med Clin (Barc)       Date:  1996-10-26       Impact factor: 1.725

6.  Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema.

Authors:  J Cordoba; J Gottstein; A T Blei
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

7.  Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy.

Authors:  L J Haseler; W L Sibbitt; H N Mojtahedzadeh; S Reddy; V P Agarwal; D M McCarthy
Journal:  AJNR Am J Neuroradiol       Date:  1998-10       Impact factor: 3.825

Review 8.  Ammonia: key factor in the pathogenesis of hepatic encephalopathy.

Authors:  R F Butterworth; J F Giguère; J Michaud; J Lavoie; G P Layrargues
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr

9.  Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy.

Authors:  W Nolte; J Wiltfang; C G Schindler; K Unterberg; M Finkenstaedt; P D Niedmann; H Hartmann; G Ramadori
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

10.  Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations.

Authors:  J Kulisevsky; J Pujol; J Balanzó; C Junqué; J Deus; A Capdevilla; C Villanueva
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

View more
  2 in total

1.  Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy.

Authors:  Sergei Mechtcheriakov; Michael Schocke; André Kugener; Ivo W Graziadei; Michael Mattedi; Hartmann Hinterhuber; Wolfgang Vogel; Josef Marksteiner
Journal:  Neuroradiology       Date:  2005-01-18       Impact factor: 2.804

Review 2.  Encephalopathy and liver transplantation.

Authors:  Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2012-11-16       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.